MyMD Pharmaceuticals News

MyMD Pharmaceuticals | 424B5: Prospectus

Feb 23, 2023 09:00 ET

MyMD Pharmaceuticals | 424B5: Prospectus

Aug 17, 2022 15:00 ET

MyMD Pharmaceuticals | EFFECT: Others

May 12, 2021 00:15 ET

MyMD Pharmaceuticals | 424B3: Prospectus

May 11, 2021 16:27 ET

MyMD Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Apr 13, 2021 09:05 ET

MyMD Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Apr 12, 2021 09:21 ET

MyMD Pharmaceuticals | EFFECT: Others

Mar 24, 2021 00:15 ET

MyMD Pharmaceuticals | 424B3: Prospectus

Mar 23, 2021 13:44 ET

MyMD Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Mar 22, 2021 17:21 ET

MyMD Pharmaceuticals | S-4/A: Registration of securities issued in business combination transactions (Amendment)

Mar 19, 2021 14:01 ET

MyMD Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Feb 18, 2021 09:00 ET

MyMD Pharmaceuticals | S-4: Registration of securities issued in business combination transactions

Jan 15, 2021 17:24 ET

MyMD Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Dec 2, 2020 16:59 ET

MyMD Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Nov 19, 2020 08:48 ET

MyMD Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Nov 18, 2020 16:50 ET

MyMD Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Nov 18, 2020 16:40 ET

MyMD Pharmaceuticals | 8-A12B: Registration of a class of securities on a national securities exchange

Sep 9, 2020 16:55 ET

MyMD Pharmaceuticals | 424B3: Prospectus

Sep 8, 2020 17:30 ET

MyMD Pharmaceuticals | EFFECT: Others

Aug 26, 2020 00:15 ET

MyMD Pharmaceuticals | 424B5: Prospectus

Aug 13, 2020 08:40 ET